Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)

Table 7 Results of the multivariate analysis of prognostic factors on overall survival, disease-free survival, local control

Factor	Factor	P value	95%CI	HR
Overall Survival	MRF+/MRF-	0.023	4.802–1.240	18.590
Disease-free Survival	MRF+/MRF-	0.011	2.231–1.203	4.136
Disease-free Survival	Poor response/Good response	0.047	1.959–1.007	3.808
Local Control	MRF+/MRF-	0.010	2.971–1.297	6.802

ISSN: 1748-717X